Menu

Infographic: Exploring New Therapeutic Targets in ALS

Biological insights from the last decade of research on amyotrophic lateral sclerosis are revealing novel opportunities for treatment.

Sep 1, 2018
Jenny Rood

ABOVE: KOTO FEJA

Research over the last 10 years has unveiled numerous disease mechanisms in amyotrophic lateral sclerosis (ALS), most of which act in motor neurons. These new insights into ALS biology are allowing drug developers to shift from focusing on downstream targets and pathways, such as inflammation or muscle weakness, to upstream mechanisms more likely to drive the disease.

Therapies currently under development may target one of several processes linked to ALS, including:

1 Inflammation of the cell body

2 Aggregation of proteins in the cell cytoplasm

3 Defects in nuclear pore complexes 

Dysregulation of mRNA processing

5 Dysregulation of microRNAs 

the scientist staff

Read the full story

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.
Corning Introduces New 1536-well Spheroid Microplate
Corning Introduces New 1536-well Spheroid Microplate
High-throughput spheroid microplate benefits cancer research, drug screening